These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 2969772

  • 1. Plasma cortisol, prolactin, growth hormone, and immunoreactive beta-endorphin response to fenfluramine challenge in depressed patients.
    Weizman A, Mark M, Gil-Ad I, Tyano S, Laron Z.
    Clin Neuropharmacol; 1988 Jun; 11(3):250-6. PubMed ID: 2969772
    [Abstract] [Full Text] [Related]

  • 2. Plasma levels of beta-endorphin, cortisol, prolactin and growth hormone in depressed patients.
    Galard R, Gallart J, Arguello JM, Schwartz S, Castellanos JM, Catalán R.
    Acta Psychiatr Scand; 1988 Aug; 78(2):230-3. PubMed ID: 2975911
    [Abstract] [Full Text] [Related]

  • 3. Cortisol, ACTH, prolactin and beta-endorphin responses to fenfluramine administration in major-depressed patients.
    Maes M, Jacobs MP, Suy E, Minner B, Raus J.
    Neuropsychobiology; 1989 Aug; 21(4):192-6. PubMed ID: 2561010
    [Abstract] [Full Text] [Related]

  • 4. The effect of acute and repeated electroconvulsive treatment on plasma beta-endorphin, growth hormone, prolactin and cortisol secretion in depressed patients.
    Weizman A, Gil-Ad I, Grupper D, Tyano S, Laron Z.
    Psychopharmacology (Berl); 1987 Aug; 93(1):122-6. PubMed ID: 2957720
    [Abstract] [Full Text] [Related]

  • 5. Neuroendocrine response to trihexyphenidyl in depressed patients.
    Valevski A, Gil-Ad I, Modai I, Apter A, Tyano S, Laron Z, Weizman A.
    Clin Neuropharmacol; 1992 Feb; 15(1):27-33. PubMed ID: 1576596
    [Abstract] [Full Text] [Related]

  • 6. Immunoreactive beta-endorphin, cortisol, and growth hormone plasma levels in obsessive-compulsive disorder.
    Weizman R, Gil-Ad I, Hermesh H, Munitz H, Laron Z.
    Clin Neuropharmacol; 1990 Aug; 13(4):297-302. PubMed ID: 2208181
    [Abstract] [Full Text] [Related]

  • 7. Reduced prolactin and cortisol responses to d-fenfluramine in depressed compared to healthy matched control subjects.
    Cleare AJ, Murray RM, O'Keane V.
    Neuropsychopharmacology; 1996 May; 14(5):349-54. PubMed ID: 8703303
    [Abstract] [Full Text] [Related]

  • 8. Hormonal responses to fenfluramine in depressed and control subjects.
    Mitchell P, Smythe G.
    J Affect Disord; 1990 May; 19(1):43-51. PubMed ID: 2140846
    [Abstract] [Full Text] [Related]

  • 9. Hormone responses to fenfluramine and placebo challenge in endogenous depression.
    Lichtenberg P, Shapira B, Gillon D, Kindler S, Cooper TB, Newman ME, Lerer B.
    Psychiatry Res; 1992 Aug; 43(2):137-46. PubMed ID: 1410069
    [Abstract] [Full Text] [Related]

  • 10. Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function.
    O'Keane V, Dinan TG.
    Am J Psychiatry; 1991 Aug; 148(8):1009-15. PubMed ID: 1853948
    [Abstract] [Full Text] [Related]

  • 11. Serotonergic regulation of prolactin and growth hormone secretion in man.
    Lewis DA, Sherman BM.
    Acta Endocrinol (Copenh); 1985 Oct; 110(2):152-7. PubMed ID: 4060968
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. D-fenfluramine-induced prolactin and cortisol release in major depression: response to treatment.
    O'Keane V, McLoughlin D, Dinan TG.
    J Affect Disord; 1992 Nov; 26(3):143-50. PubMed ID: 1460163
    [Abstract] [Full Text] [Related]

  • 14. Growth hormone (GH) and prolactin responses after GH-releasing hormone in major depressive disorder: relationship to somatomedin C levels and dexamethasone suppressibility of cortisol.
    Lesch KP, Laux G, Erb A, Pfüller H, Beckmann H.
    Psychoneuroendocrinology; 1988 Nov; 13(3):255-63. PubMed ID: 3136488
    [Abstract] [Full Text] [Related]

  • 15. HPA-axis hormones and prolactin responses to dextro-fenfluramine in depressed patients and healthy controls.
    Maes M, D'Hondt P, Suy E, Minner B, Vandervorst C, Raus J.
    Prog Neuropsychopharmacol Biol Psychiatry; 1991 Nov; 15(6):781-90. PubMed ID: 1662403
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The effects of cortisol infusion upon hormone secretion from the anterior pituitary and subjective mood in depressive illness and in controls.
    Goodwin GM, Muir WJ, Seckl JR, Bennie J, Carroll S, Dick H, Fink G.
    J Affect Disord; 1992 Oct; 26(2):73-83. PubMed ID: 1332993
    [Abstract] [Full Text] [Related]

  • 18. Cortisol and prolactin responses to d-fenfluramine in non-depressed patients with obsessive-compulsive disorder: a comparison with depressed and healthy controls.
    Lucey JV, O'Keane V, Butcher G, Clare AW, Dinan TG.
    Br J Psychiatry; 1992 Oct; 161():517-21. PubMed ID: 1393339
    [Abstract] [Full Text] [Related]

  • 19. Adrenocorticotropic hormone, beta-endorphin, cortisol, growth hormone and prolactin circulating levels in nineteen athletes before and after half-marathon and marathon.
    Scavo D, Barletta C, Vagiri D, Letizia C.
    J Sports Med Phys Fitness; 1991 Sep; 31(3):401-6. PubMed ID: 1665889
    [Abstract] [Full Text] [Related]

  • 20. Depression in premenopausal women: gonadal hormones and serotonergic system assessed by D-fenfluramine challenge test.
    Rajewska J, Rybakowski JK.
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Jun; 27(4):705-9. PubMed ID: 12787860
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.